Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study

Pierfrancesco Bassi, Vincenzo Mirone, Davide Arcaniolo, David Rivas, Scott Bull, Joseph W. Aquilina, Paolo Verze

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor and the first drug approved for the on-demand treatment of premature ejaculation (PE). Its safety was established in a thorough clinical development program.
Original languageEnglish
Pages (from-to)733-739
Number of pages7
JournalEUROPEAN UROLOGY
Volume65
DOIs
Publication statusPublished - 2014

Keywords

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Benzylamines
  • Cardiovascular events
  • Complementary Therapies
  • Dapoxetine
  • Humans
  • Male
  • Middle Aged
  • Naphthalenes
  • Premature Ejaculation
  • Prospective Studies
  • Safety
  • Serotonin Uptake Inhibitors
  • Syncope
  • Young Adult

Fingerprint

Dive into the research topics of 'Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study'. Together they form a unique fingerprint.

Cite this